제품 수집
제품 세부정보
Synonyms
BTLA, CD272
Source
Human BTLA (31-150) (M105V, G138S, V148M), Fc Tag (BTA-H5254) is expressed from human 293 cells (HEK293). It contains AA Lys 31 - Ser 150 (Accession # AAP44003.1 (M105V, G138S, V148M)).
Predicted N-terminus: Lys 31
Request for sequenceMolecular Characterization
Other Tags and Version Biotin & Other Labeled Version
This protein carries a human IgG1 Fc tag at the C-terminus.
The protein has a calculated MW of 40.2 kDa. The protein migrates as 50-60 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
Endotoxin
Less than 1.0 EU per μg by the LAL method / rFC method.
Purity
>95% as determined by SDS-PAGE.
Formulation
Lyophilized from 0.22 μm filtered solution in 50 mM Tris, 100 mM Glycine, 25 mM Arginine, 150 mM NaCl, pH7.5 with trehalose as protectant.
Contact us for customized product form or formulation.
Reconstitution
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 12 months in lyophilized state;
- -70°C for 3 months under sterile conditions after reconstitution.
ACRO Quality Management System
고객님도 확인한 상품
데이터 표시
SDS-PAGE
Human BTLA (31-150) (M105V, G138S, V148M), Fc Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.
SEC-MALS
The purity of Human BTLA (31-150) (M105V, G138S, V148M), Fc Tag (Cat. No. BTA-H5254) is more than 85% and the molecular weight of this protein is around 95-115 kDa verified by SEC-MALS.
Report
Bioactivity-ELISA
Immobilized Human HVEM, His Tag (Cat. No. HVM-H52E9) at 5 μg/mL (100 μL/well) can bind Human BTLA (31-150) (M105V, G138S, V148M), Fc Tag (Cat. No. BTA-H5254) with a linear range of 0.02-0.8 ng/mL (QC tested).
Protocol
사용자 리뷰 댓글 남기기
FAQ
- Product
Why are different expression ranges (31–134 and 31–150) used for human BTLA proteins?
The different lengths of human BTLA proteins correspond to different isoforms. The aa31–134 sequence represents isoform 2, while aa31–150 corresponds to isoform 1. ACRO provides BTLA proteins of varying lengths to meet diverse customer requirements.
배경 소개
프론티어 진행
의약품 개발 진행- 영어 이름：
B- and T-lymphocyte attenuator
- 카테고리：
- 상장 의약품 수：
0 상세
- 임상 의약품 수：
6 상세
- 최고 개발 단계：
Phase 3 Clinical
연락하기
전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521
신약 후보물질 라이선싱
